Report Scope:

The report would cover the Genomics and Proteomics Tools market, dynamics and competitive landscape of the Emerging markets in the Asia-Pacific. Key countries to be covered includes-China, South Korea and India. The market would cover products or tools for performing genomics and proteomics studies. Technologies and the products that would be covered in the report include- Sequencing technologies-Sangers Sequencing & Next Generation Sequencing, PCR Technologies, Flow Cytometry, Mass Spectrometry, Nucleic Acid Sample Preparation technologies(technique) and Separation Technologies for Nucleic Acids. A competitive Landscape for key selected technologies is covered along with profiles of manufacturers engaged in providing related technological products or services.

Report Includes -

  • 22 data tables and 20 additional tables
  • An overview of the Asia-Pacific (APAC) markets for genomics and proteomic tools within the life sciences industry
  • Country-specific data and market analysis of genomics and proteomic technologies for China, India, South Korea and other emerging economies
  • Analyses of the APAC market trends, with data from 2018 to 2019, and projections of compound annual growth rates (CAGRs) through 2023
  • Information on factors driving the industry’s growth, current trends and opportunities, regulatory challenges and technological advancements that will shape the future - marketplace within APAC region
  • Identification of the companies best-positioned to meet the enormous supply demand equation because of their proprietary technologies, strategic alliances or other advantages
  • Assessment of the competitive landscape and data corresponding to shares of leading market participants
  • Patent study and analysis covering significant allotments of the U.S. patents
  • Company profiles of leading market players within the APAC emerging markets, including 3Billion Inc., Bio-Rad Laboratories Inc., GE Healthcare, Novogene Corp., Qiagen NV, Thermo Fisher Scientific Inc., and Waters Corp.